Tag: Treatment
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with...
BioCryst Presents New Real-world Evidence Showing Reductions in Attack Rates in HAE Patients with Normal C1-Inhibitor after Beginning ORLADEYO® (berotralstat) TreatmentIn a recent presentation...
Pharming Group provides update on ongoing regulatory review of leniolisib for the treatment of...
Pharming Group Provides Update on Ongoing Regulatory Review of Leniolisib for the Treatment of APDS in the European UnionLeiden, the Netherlands, May 30, 2024...
Breaking Financial News
X’s New Terms of Service Causing Users to Leave Elon Musk’s...
Elon Musk's platform, X, has recently implemented new terms of service that have caused some users to leave the microblogging platform. These new terms...
